Loading...
Kodiak Sciences Inc.
KOD•NASDAQ
Healthcare
Biotechnology
$8.84
$0.59(7.15%)
Kodiak Sciences Inc. (KOD) Financial Performance & Income Statement Overview
Review Kodiak Sciences Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
32.62%
↑ 32.62%
Net Income Growth
32.36%
↑ 32.36%
Operating Cash Flow Growth
23.91%
↑ 23.91%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-80.83%
↓ 80.83%
ROIC
-74.85%
↓ 74.85%
Kodiak Sciences Inc. (KOD) Income Statement & Financial Overview
Review Kodiak Sciences Inc.'s (KOD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $6.68M | $6.65M |
| Gross Profit | $0.00 | $0.00 | -$6.68M | -$6.65M |
| Gross Profit Ratio | ||||
| R&D Expenses | $31.77M | $31.88M | $32.51M | $29.93M |
| SG&A Expenses | $14.41M | $14.75M | $15.47M | $9.48M |
| Operating Expenses | $46.18M | $46.63M | $47.98M | $39.41M |
| Total Costs & Expenses | $46.18M | $46.63M | $47.98M | $46.05M |
| Interest Income | $2.13M | $2.71M | $2.95M | $3.35M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $6.68M | $6.70M | $6.68M | $6.65M |
| EBITDA | -$37.42M | -$37.25M | -$38.44M | -$36.39M |
| EBITDA Ratio | ||||
| Operating Income | -$46.18M | -$46.63M | -$47.98M | -$46.05M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $2.07M | $2.69M | $2.87M | $3.02M |
| Income Before Tax | -$44.10M | -$43.95M | -$45.12M | -$43.04M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $6.60M |
| Net Income | -$44.10M | -$43.95M | -$45.12M | -$43.04M |
| Net Income Ratio | ||||
| EPS | -$0.84 | -$0.84 | -$0.86 | -$0.82 |
| Diluted EPS | -$0.84 | -$0.84 | -$0.86 | -$0.82 |
| Weighted Avg Shares Outstanding | $52.65M | $52.62M | $52.55M | $52.51M |
| Weighted Avg Shares Outstanding (Diluted) | $52.65M | $52.62M | $52.55M | $52.51M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan